Kevin Bernard Churchwell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Faculty, Medical | 1 | 2022 | 1181 | 0.460 |
Why?
|
| Social Responsibility | 1 | 2008 | 389 | 0.260 |
Why?
|
| Hospital Administration | 1 | 2008 | 353 | 0.240 |
Why?
|
| Meningococcal Infections | 2 | 1995 | 77 | 0.230 |
Why?
|
| Safety Management | 1 | 2009 | 783 | 0.230 |
Why?
|
| Medical Errors | 1 | 2009 | 1297 | 0.190 |
Why?
|
| Research | 1 | 2009 | 1999 | 0.190 |
Why?
|
| Information Dissemination | 1 | 2008 | 1099 | 0.180 |
Why?
|
| Diabetic Ketoacidosis | 2 | 2007 | 245 | 0.170 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 2212 | 0.160 |
Why?
|
| Veratridine | 1 | 1996 | 24 | 0.150 |
Why?
|
| Bacteremia | 2 | 1995 | 962 | 0.150 |
Why?
|
| Purpura | 2 | 1995 | 122 | 0.140 |
Why?
|
| Schools, Medical | 1 | 2022 | 880 | 0.130 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1995 | 56 | 0.130 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1995 | 110 | 0.120 |
Why?
|
| Pediatrics | 1 | 2009 | 3475 | 0.120 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1995 | 188 | 0.120 |
Why?
|
| Plasma Exchange | 1 | 1995 | 152 | 0.120 |
Why?
|
| Brain Abscess | 1 | 1995 | 118 | 0.120 |
Why?
|
| Partial Thromboplastin Time | 1 | 1993 | 206 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1996 | 895 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 2759 | 0.100 |
Why?
|
| Sodium | 1 | 1996 | 1623 | 0.100 |
Why?
|
| Blood Coagulation Disorders | 1 | 1993 | 337 | 0.090 |
Why?
|
| Fibrinogen | 1 | 1993 | 894 | 0.090 |
Why?
|
| Governing Board | 1 | 2008 | 53 | 0.080 |
Why?
|
| Clostridium Infections | 1 | 1995 | 548 | 0.080 |
Why?
|
| Morbidity | 1 | 1993 | 1769 | 0.080 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2007 | 981 | 0.070 |
Why?
|
| Factor VIIa | 1 | 2007 | 101 | 0.070 |
Why?
|
| Leukapheresis | 1 | 2006 | 131 | 0.070 |
Why?
|
| Status Asthmaticus | 1 | 2006 | 22 | 0.070 |
Why?
|
| Professional Role | 1 | 2009 | 306 | 0.070 |
Why?
|
| Anions | 2 | 1996 | 133 | 0.070 |
Why?
|
| Hospital Charges | 1 | 2008 | 362 | 0.070 |
Why?
|
| Whooping Cough | 1 | 2006 | 82 | 0.070 |
Why?
|
| Cardiac Output, Low | 1 | 2006 | 195 | 0.070 |
Why?
|
| Organizational Culture | 1 | 2009 | 510 | 0.070 |
Why?
|
| Vena Cava, Superior | 1 | 2006 | 193 | 0.060 |
Why?
|
| Peptic Ulcer | 1 | 2006 | 223 | 0.060 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2007 | 1354 | 0.060 |
Why?
|
| Child | 9 | 2022 | 77709 | 0.060 |
Why?
|
| Postoperative Hemorrhage | 1 | 2007 | 413 | 0.060 |
Why?
|
| Isoflurane | 1 | 2006 | 380 | 0.050 |
Why?
|
| Child, Preschool | 9 | 2009 | 41006 | 0.050 |
Why?
|
| Hospital Mortality | 3 | 2005 | 5317 | 0.050 |
Why?
|
| Anesthetics, Inhalation | 1 | 2006 | 570 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 1996 | 5708 | 0.050 |
Why?
|
| Leadership | 1 | 2009 | 1357 | 0.040 |
Why?
|
| Appendicitis | 1 | 2006 | 645 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2006 | 1130 | 0.040 |
Why?
|
| Thoracic Surgery | 1 | 2005 | 719 | 0.040 |
Why?
|
| Intracellular Membranes | 2 | 1996 | 390 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2006 | 1403 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 1199 | 0.040 |
Why?
|
| Water-Electrolyte Balance | 2 | 1996 | 346 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 1912 | 0.040 |
Why?
|
| Neurons | 1 | 1996 | 9338 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2006 | 2132 | 0.040 |
Why?
|
| Heart Defects, Congenital | 2 | 2005 | 4584 | 0.040 |
Why?
|
| Dizocilpine Maleate | 1 | 1996 | 176 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 2872 | 0.030 |
Why?
|
| Brain Edema | 2 | 1996 | 617 | 0.030 |
Why?
|
| Infant | 7 | 2007 | 35136 | 0.030 |
Why?
|
| Cell Physiological Phenomena | 1 | 1995 | 154 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1996 | 449 | 0.030 |
Why?
|
| Humans | 16 | 2022 | 744343 | 0.030 |
Why?
|
| Metronidazole | 1 | 1995 | 217 | 0.030 |
Why?
|
| Chlorides | 1 | 1996 | 667 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2008 | 4371 | 0.030 |
Why?
|
| Potassium | 1 | 1996 | 1336 | 0.030 |
Why?
|
| Insulin | 1 | 2007 | 6580 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 1996 | 593 | 0.030 |
Why?
|
| Penicillins | 1 | 1995 | 380 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 3537 | 0.030 |
Why?
|
| Ion Channels | 1 | 1996 | 1056 | 0.030 |
Why?
|
| Disease | 1 | 1995 | 680 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 2025 | 0.020 |
Why?
|
| Survival Rate | 3 | 2005 | 12788 | 0.020 |
Why?
|
| Shock, Septic | 1 | 1995 | 775 | 0.020 |
Why?
|
| Insulin, Long-Acting | 1 | 2007 | 57 | 0.020 |
Why?
|
| Syndrome | 1 | 1993 | 3251 | 0.020 |
Why?
|
| Retrospective Studies | 7 | 2007 | 77449 | 0.020 |
Why?
|
| Hypertension | 1 | 2006 | 8480 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2007 | 666 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 8301 | 0.020 |
Why?
|
| United States | 3 | 2008 | 69872 | 0.020 |
Why?
|
| Homeostasis | 1 | 1995 | 3340 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2007 | 25625 | 0.010 |
Why?
|
| Heart Arrest | 2 | 2005 | 1470 | 0.010 |
Why?
|
| Calcium | 1 | 1996 | 5756 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2006 | 1105 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2006 | 1588 | 0.010 |
Why?
|
| Adolescent | 4 | 2007 | 85781 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2006 | 987 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2007 | 1066 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1996 | 19229 | 0.010 |
Why?
|
| Rats | 1 | 1996 | 24260 | 0.010 |
Why?
|
| Liver | 1 | 1996 | 7474 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2001 | 15295 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 3508 | 0.010 |
Why?
|
| Male | 8 | 2007 | 350118 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1993 | 7729 | 0.010 |
Why?
|
| Prognosis | 2 | 2001 | 29063 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1993 | 14722 | 0.010 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2005 | 980 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6622 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2006 | 1475 | 0.010 |
Why?
|
| Resuscitation | 1 | 2001 | 658 | 0.010 |
Why?
|
| Osmosis | 1 | 1995 | 113 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1993 | 15540 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1996 | 411 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2006 | 2569 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1993 | 19905 | 0.010 |
Why?
|
| Ion Transport | 1 | 1995 | 320 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2007 | 63114 | 0.010 |
Why?
|
| Echocardiography | 1 | 2006 | 5102 | 0.010 |
Why?
|
| Length of Stay | 1 | 2007 | 6309 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 1996 | 437 | 0.010 |
Why?
|
| Cell Size | 1 | 1995 | 643 | 0.010 |
Why?
|
| Inflammation | 1 | 1993 | 10638 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 1996 | 964 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2006 | 6442 | 0.010 |
Why?
|
| Female | 6 | 2007 | 380194 | 0.010 |
Why?
|
| Animals | 3 | 1996 | 168757 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 21746 | 0.010 |
Why?
|
| Critical Care | 1 | 2001 | 2647 | 0.010 |
Why?
|
| Cell Division | 1 | 1995 | 4568 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1995 | 35421 | 0.000 |
Why?
|
| Anemia, Sickle Cell | 1 | 1995 | 1018 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2007 | 40561 | 0.000 |
Why?
|
| Time Factors | 1 | 2005 | 40075 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1995 | 5751 | 0.000 |
Why?
|